ornithine and Diabetic Angiopathies

ornithine has been researched along with Diabetic Angiopathies in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kövamees, O; Pernow, J; Shemyakin, A	1
Checa, A; Kövamees, O; Lundberg, JO; Östenson, CG; Pernow, J; Shemyakin, A; Wheelock, CE	1
Eder, M; Meinitzer, A; Pieber, TR; Sourij, H; Tripolt, NJ; Wascher, TC	1

Trials

2 trial(s) available for ornithine and Diabetic Angiopathies

Article	Year
Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus. The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:11 Topics: Acetylcholine; Aged; Arginase; Arginine; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; Nitroprusside; Ornithine; Peripheral Vascular Diseases; Severity of Illness Index; Vascular Resistance; Vasodilation; Vasodilator Agents	2016
Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios. Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:10 Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors	2012

Article

Year

Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.

The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:11

Topics: Acetylcholine; Aged; Arginase; Arginine; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Laser-Doppler Flowmetry; Male; Microvessels; Middle Aged; Nitroprusside; Ornithine; Peripheral Vascular Diseases; Severity of Illness Index; Vascular Resistance; Vasodilation; Vasodilator Agents

2016

Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.

Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:10

Topics: Aged; Anticholesteremic Agents; Arginine; Biological Availability; Blood Pressure; Cholesterol, LDL; Citrulline; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Prospective Studies; Risk Factors; Time Factors

2012

Other Studies

1 other study(ies) available for ornithine and Diabetic Angiopathies

Article	Year
Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction. Diabetes & vascular disease research, 2016, Volume: 13, Issue:5 Topics: Aged; Arginase; Arginine; Biomarkers; Case-Control Studies; Citrulline; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Up-Regulation; Vasodilation	2016

Article

Year

Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.

Diabetes & vascular disease research, 2016, Volume: 13, Issue:5

Topics: Aged; Arginase; Arginine; Biomarkers; Case-Control Studies; Citrulline; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide Synthase; Ornithine; Up-Regulation; Vasodilation

2016